Some links on this page are affiliate links: if you buy through them we may earn a commission, at no extra cost to you.
The reliable way to find an AI-developed cancer treatment is to search broadly, then verify narrowly. Start with the patient’s diagnosis, stage, previous treatment, tumor biomarkers, age, medical history, health status, and travel limits. Search both the National Cancer Institute (NCI) clinical-trial service and ClinicalTrials.gov using the cancer, intervention, sponsor, and AI-related terms. Open each complete protocol record to check phase, recruitment status, eligibility, locations, contacts, and whether the AI-derived treatment is actually given to participants. “AI-developed” is not a guarantee of effectiveness, approval, safety, or eligibility; ask the investigator to identify exactly how AI was used and review the result with the treating oncologist.
What information should I gather before searching?
Clinical-trial eligibility is based on clinical details, not on an AI label. Assemble a concise, current record before searching so you can recognize plausible studies and give the trial team accurate information.
As an Amazon Associate I earn from qualifying purchases.
Do these 3 things before closing this tab:
1Clear out junk files and repair common Windows errors2Fix the driver behind crashes, sound loss and screen glitches3Repair Windows errors before they cause bigger problems- Cancer: exact cancer type, primary site, histology, stage, and whether it has spread or returned.
- Treatment history: every major therapy, dates, response, progression, intolerance, and what you are receiving now.
- Biomarkers: tumor mutations, fusions, protein expression, microsatellite status, tumor-mutational burden, or other results from pathology and genomic reports.
- Personal factors: age, performance or activity level, other illnesses, organ-function problems, allergies, infections, and previous adverse reactions.
- Practical limits: home location, willingness to travel, language or accessibility needs, caregiver availability, insurance questions, and whether frequent visits are feasible.
- Goals: treatment of active disease, maintenance, prevention of recurrence, symptom relief, or participation in a study that may help future patients.
Keep the pathology report, imaging summaries, medication list, laboratory results, and genomic report available. A trial site may require its own confirmation tests, so your records help with initial screening but do not establish eligibility.
Where can I search for cancer trials that mention AI?
Use more than one database. The NCI explains that, because sponsors vary, no single list contains every clinical trial. NCI’s database and ClinicalTrials.gov overlap but are not interchangeable.
#1 Best Overall
- [Ultra-Lightweight Ear Buds Designed for Small Ears] Each earbud weighs only 3.7g and features a compact, ergonomic in-ear design made especially for small ears. Secure, low-profile, and comfortable for workouts, all-day wear or overnight sleeping.The ultra-slim profile sits flush in your ear with no hard edges poking or rubbing, so you can even sleep on your side without discomfort.
- [Immersive Stereo Sound with TOZO OrigX Technology] TOZO OrigX tuning delivers clear vocals, balanced mids, and natural stereo sound for music, podcasts, and videos.
- [Long Battery Life for Daily Use] Get up to 7 hours of playtime on a single charge, with up to 32 hours total using the charging case—ideal for workdays, commuting, and extended listening sessions.
- [Bluetooth 5.3 & Stable Connection] Bluetooth 5.3 provides fast pairing, stable wireless performance, and reduced dropouts as you move around home or office.
- [Deep Bass with Clear Vocals] High-performance drivers produce punchy bass while keeping vocals clean and detailed for everyday listening.
Start with the NCI Cancer Clinical Trials Search
Use the NCI search to filter by cancer type, treatment or drug, trial phase, location, lead organization, and trial type. Save the protocol summary for every plausible result. NCI says a protocol summary should describe the study’s goal, treatments, and locations; those fields let you discard clearly irrelevant studies before investing time in the full record.
NCI’s Cancer Information Service can also provide a tailored search that you can discuss with your doctor. NCI explicitly cautions that search results do not replace medical advice.
The Tool Desk
Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →Repeat the search on ClinicalTrials.gov
ClinicalTrials.gov is maintained by the U.S. National Library of Medicine. The sponsor or investigator submits the record and is responsible for its safety, scientific content, and accuracy. Search the disease, intervention, sponsor, location, and AI terms separately and in combinations. A pharmaceutical or biotechnology study may appear there even when it is absent from an NCI list.
Because registry wording is sponsor-submitted, treat an “AI,” “machine learning,” or “AI-designed” phrase as a lead to verify, not as independent proof that the medicine was discovered or designed with AI.
Check institution and sponsor listings
Look at trial pages for NCI-designated cancer centers, academic hospitals, biotechnology or pharmaceutical companies, and relevant patient-advocacy organizations. These pages can expose local recruiting contacts or studies that are difficult to find with a broad keyword search. Confirm every result against the current registry or the study team; an institution’s page can remain online after recruitment changes.
Which search terms find AI-related studies?
No single phrase is used consistently. Run several searches, then combine the useful terms with the cancer type, biomarker, drug name, sponsor, and location.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
Rank #2
- 【IP68 Waterproof Multifunctinal Smart Watch】Torjalph fitness activity tracker smart watch is IP68 waterproof technology ,you can wear it when swimming,handwashing,it's rain-proof which means that you perform multiple exercise modes outside without worrying about sweat or rain corroding your fitness smart watch,and this watch equipped with a 230 mAh large capacity battery magnetic charging ,and this sports activity tracker watch can be used 5-7 days If fully charged.
- 【Larger 1.83'' Full Screen Watch & Multi-dial Selection】1.83 inch full HD color touch screen smart watch for men / women provides excellent 240*284 resolution image quality ,This Bluetooth smart watch offers a better touch experience and remarkable immersion and ,more than 200 watch faces for you to choose from App"Da Fit ", you can change the dial style according to your mood to wear keeping the world on your wrist
- 【Accurate Activity Tracker Smart Watch 】sports watch activity tracker uses sweat and dust resistant breathable silicone strap, our Fitness Tracker Smart Watch for Android iOS Phones supports 12 sports modes,walking,running,bicycle,swimming,badminton,basketball,football,rope skipping. This bluetooth calls smart watch for men women is lightweight and stylish, bringing more convenient and relaxing sports experience while also providing more protection.
- 【Your 24 Hour Personal Daily Health Monitor】Fitness watch for women men full touch screen IP67 waterproof bluetooth smartwatch for Android iOS Phones with heart rate blood pressure monitor multifunction Andriod smart watch with steps counter sleep monitor sports fitness watch, monitoring blood oxygen saturation allows you to understand your physical condition in real time to track fitness progress ,to know your health status in time.
- 【More Functions Bluetooth Call Smart Watch】This fitness activity smart watch full screen for iPhone and Android phones includes a bunch of new features including:The bluetooth smart watch can hang up the phone, receive and display WhatsAPP /Text /Facebook /Twitter /Messenger reminder.Support sedentary reminder, alarm clock, stopwatch, timer,weather information,music control, remote camera control compatible with Android 5.0 and above or iOS 9.0 and above smartphones.
- “artificial intelligence”
- “machine learning”
- “AI-designed”
- “AI-discovered”
- “generative chemistry”
- “drug design” or “molecule design”
- the suspected drug, program, or sponsor name
- terms for the relevant cancer and biomarker
Search each concept in quotation marks and without quotation marks where the database permits. Also search the ordinary intervention name without “AI”: a registry may describe a compound but omit the method used to create it. Conversely, a study may use AI for imaging, diagnosis, recruitment, manufacturing, dose selection, or data analysis while administering a conventional drug. Those are different questions from finding a drug whose target or molecule was developed with AI.
How do I tell whether AI was actually used to develop the drug?
Ask for the specific development step, the named technology or developer, and documentary evidence. “AI-developed” is too broad to establish what happened.
Separate drug creation from supporting uses
| AI role described | What it may mean | Does it establish an AI-developed drug? |
|---|---|---|
| Target discovery | Algorithms analyzed biological data to propose a disease target. | It may support an AI-assisted discovery claim, but ask whether the target led to the intervention in this trial. |
| Molecule or generative-chemistry design | Models proposed or optimized chemical structures. | This is the closest match to an AI-designed drug claim; verify human design, laboratory testing, and the compound’s identity. |
| Biomarker selection | Models selected patients or predicted response markers. | It concerns trial enrollment or precision medicine, not necessarily drug invention. |
| Dose optimization | Algorithms helped model dose, schedule, or exposure. | It does not show that AI discovered the molecule. |
| Imaging or diagnosis | Software interprets scans or pathology. | The trial may administer a standard treatment while studying an AI tool. |
| Recruitment, manufacturing, or data analysis | AI supports operations or research measurements. | It does not establish an AI-derived cancer medicine. |
Request a verifiable explanation
Ask the sponsor or investigator: “Which part of this program used AI, what model or platform was used, who developed it, and is the resulting intervention being administered in this study?” Request the compound’s identifier, the study identifier, the protocol or investigator brochure description, and any peer-reviewed publication or conference report the team can share. Record the answer and its date because a registry description can change.
NCI describes AI as active throughout cancer research and lists programs such as Informatics Technology for Cancer Research (ITCR), Cancer Systems Biology Consortium (CSBC), Small Business Innovation Research (SBIR), Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH), and Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI). These programs show that AI is a broad research field; they do not certify any particular marketed drug or trial as AI-developed.
Quick wins for a faster PC:
Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Repair Windows errors before they cause bigger problemsFix Now →Scan for outdated or missing drivers - takes under a minuteDriver Scan →How do I verify a candidate trial’s details?
After finding a plausible record, read the full entry rather than relying on a search-result snippet. Verify each item below before contacting the site.
- Study identifier and title: copy the identifier exactly so every conversation refers to the same protocol.
- Recruitment status: distinguish recruiting, not yet recruiting, active but not recruiting, suspended, terminated, and completed. Do not assume a study is open because an older page or news item says it is.
- Phase and purpose: early-phase dose or safety studies have different objectives from later studies testing effectiveness or comparing treatments.
- Intervention and comparator: identify the drug, dose or schedule, control arm, placebo language, and whether the AI-related intervention is actually administered.
- Eligibility: check cancer type and stage, measurable disease rules, biomarker thresholds, previous-treatment requirements, washout periods, age limits, organ-function tests, medications, and exclusions.
- Locations: list every site, the distance from home, visit frequency, and whether screening or treatment must occur at one designated center.
- Study timeline: note enrollment duration, treatment cycles, follow-up, scans, blood draws, biopsies, and the expected total commitment.
- Risks and alternatives: ask what is known about the intervention, what remains uncertain, and which standard or other trial options exist.
- Contacts: save the central contact and the nearest site contact, including telephone and email details shown in the record.
The protocol summary should explain the objective, treatment, and locations, but the detailed record is where phase, recruitment, eligibility, and contact information are confirmed. If any field conflicts with the site’s information, ask the study team which is current.
Rank #3
- [Low Noise High Fidelity] New bee guitar cord with 22AWG oxygen-free-copper center conductors provides enhanced signal transfer, the PVC insulation material and the high-density stranded copper double shield provide noise rejection for quiet operation
- [Ideal for Choice] New bee 1/4 straight and right angle metal connectors, ensures a secure connection in any instrument, pedal, or amp jack. L shape great fro on stage guitar stands
- [Wide Compatible] Suitable for mixer, power amplifier, microphone, effector, decoder, equalizer, electoronic organ, electric guitar, electric bass and other electronic equipments. Widely used in the installation of smart home, karaoke speaker, professional stage audio, etc
- [Easy Disassemble] Making incidental repairs quick and easy! Very nice, flexible cable
- [Dont Hesite to Order] 24 hours customer services and professional technology team are standing by
How should I compare two AI-related cancer trials?
Compare protocols on the factors that affect medical fit and practical feasibility, not on the novelty of the AI claim.
| Comparison point | Questions to ask |
|---|---|
| AI role and evidence | Was AI used for target discovery, molecule design, biomarker selection, dosing, or another task? What named evidence supports the claim? |
| Cancer and biomarker match | Does the protocol include this cancer subtype, stage, mutation, expression level, or prior-treatment setting? |
| Phase and objective | Is the study primarily evaluating safety, dose, pharmacokinetics, activity, or a comparison with another treatment? |
| Intervention and comparator | What is administered, how often, and what does the control group receive? |
| Eligibility burden | Are there washout periods, biopsy requirements, organ-function thresholds, or prior therapies that could exclude the patient? |
| Recruiting status | Does the live record show recruiting at a site that can actually screen the patient? |
| Location and travel | How many visits are required, and are scans, infusions, or laboratory tests available locally? |
| Study length | How long are treatment and follow-up, and what happens if the disease progresses? |
| Sponsor and investigator | Who is accountable for the study, and can the local investigator answer questions about the AI claim? |
| Risks and alternatives | What known and unknown risks apply, and what standard care or other trials remain available? |
| What participants receive | Is the AI-derived intervention given to participants, or is AI used only in a supporting research process? |
A later-phase study is not automatically better, and an AI label is not a substitute for a protocol that matches the patient’s disease and goals. Have the treating oncologist help weigh medical risk, likely burden, and alternatives.
Windows Errors? Fix Them Before They Spread
Repair common Windows errors and clear accumulated junk for a smoother, more stable PC - no reinstall needed.Free scan · no reinstallOutdated Drivers Are Slowing You Down
One free scan finds every outdated or missing driver and matches the right update for your exact hardware.Free scan · exact hardware matchWhat should I ask the investigator or trial coordinator?
Prepare questions in writing and ask for plain-language answers. Useful questions include:
- What exact AI system or method was used, and at what stage of development?
- Was the molecule proposed by a model, or did AI support a target, biomarker, dose, manufacturing, or analysis decision?
- What laboratory, animal, or earlier human evidence exists for this intervention?
- Is this study testing the AI-derived drug itself, or an AI tool alongside another treatment?
- What are the dose, schedule, route, treatment cycles, monitoring tests, and most important known risks?
- Which prior treatments, mutations, laboratory values, or medications determine eligibility?
- How often must I travel, how long is screening, and what costs or reimbursements are explained in the consent materials?
- What happens if I am ineligible, the study closes, or my disease progresses?
Ask the coordinator to confirm the recruitment status and the site’s ability to screen you now. A registry entry is not a promise of enrollment; the investigator makes the final eligibility determination after reviewing records and protocol tests.
How should I involve my oncologist?
NCI says the best place to start when considering a clinical trial is your doctor or another member of your health-care team. Share the protocol, study identifier, eligibility criteria, travel plan, and your questions. Your oncologist can interpret the trial’s phase and treatment plan alongside current standard care, prior toxicities, other medications, and personal goals.
Ask whether a second opinion at the trial center is appropriate and how participation would affect existing care. Do not stop, delay, or substitute prescribed treatment while waiting for a response from a registry or study site.
Rank #4
- Digital Family Calendar: BSIMB digital calendar wall touch screen puts an end to your chaotic life. Designed for busy families, the digital calendar keeps you organised and in step with your family. Assign different colours and tasks to each family member to make family scheduling easier and more intuitive.
- Easy Setup and Auto-Sync: Plug in, connect to WLAN and auto-syn your electric calendar in minutes. Digital wall calendar compatible with Google calendar, iCloud calendar, Outlook calendar, Cozi calendar and Yahoo calendar. Add events directly on the device or through the ecalendar app. Electronic calendar stays current whether you're at work or traveling—no manual updates needed.
- All-In-One Home Assistant: Smart calendar builds habits and encourage independence with personalised chores. Display daily meal plan to reduce the daily ‘What's for dinner?’ stress. To-do lists keep track of everything you want. Turning chores into valuable achievements with stars and rewards, making life easier and more enjoyable.
- Manage Anytime Anywhere: BSIMB electronic calendar for family stay connected with the powerful ecalendar app. Access and manage your digital wall calendar anytime, anywhere with free features like stars & rewards, photo screensaver, chore charts, meals plans, to-do lists etc. Electronic planner paid features like Magic Import tailor advanced tools for users with special needs.
- Stay in Touch with Loved Ones: Share photos or videos from your phone to electronic wall calendar with app, instantly update your life moment, and keep in touch with your family, especially those who are far away; you can also surprise your smart calendar digital wall by sending him a wish card; it's also great for keeping tech-illiterate elders in touch with the youngsters.
Can I obtain an experimental AI-developed drug without joining a trial?
Usually, the clinical trial is the normal route. NCI calls a clinical trial “the most common and preferred way to access an experimental drug.” Expanded access and right-to-try are separate, exceptional pathways with medical, sponsor, and regulatory conditions; they are not ordinary purchasing options.
If a trial is unavailable, ask the oncologist whether an applicable expanded-access process exists and whether the sponsor is willing to provide the drug. The treating physician, sponsor, and regulators may each have requirements, and access is not guaranteed. Never buy an investigational cancer drug from an unverified seller or assume that an AI claim indicates regulatory authorization.
What common search mistakes should I avoid?
Relying on one registry
NCI and ClinicalTrials.gov have different coverage. Search both, then check relevant cancer-center, hospital, sponsor, and advocacy listings.
Confusing an AI tool with an AI drug
A study can use machine learning for scans, diagnosis, recruitment, or analysis while giving participants a conventional medicine. Identify the exact intervention and the exact AI task.
Recommended Free Tools
Reading “recruiting” as a guarantee
Status changes by site and over time. Confirm the live record and call the local contact before arranging travel.
Assuming a press release proves clinical benefit
Discovery claims, laboratory results, and early signals do not establish effectiveness or safety for a particular patient. Ask for the protocol, phase, human data, and uncertainties.
Ignoring eligibility details
Stage, prior therapy, biomarkers, organ function, washout periods, and current health can matter more than the drug’s development story. Let the site perform formal screening.
Leaving practical burden until the end
Frequent visits, biopsies, scans, and long follow-up can determine whether participation is realistic. Map travel, caregiver time, work obligations, and emergency arrangements before consenting.
What should I keep in a personal trial-search worksheet?
For each candidate, keep one row or page with:
- study identifier, title, sponsor, investigator, and date checked;
- cancer type, stage, biomarker, and prior-treatment match;
- AI role, named platform or developer, and evidence supplied;
- phase, objective, intervention, comparator, and treatment schedule;
- recruitment status and the exact site contacted;
- screening tests, exclusion criteria, visit schedule, and estimated duration;
- known risks, unanswered questions, alternatives, and oncologist’s comments;
- contact names, phone numbers, email addresses, and the date of the next follow-up.
This record prevents two frequent errors: treating the same study as several different opportunities and losing the source of an AI claim when a web page changes.
What is the practical bottom line?
Search NCI and ClinicalTrials.gov with both medical and AI terminology, expand to center and sponsor listings, and then verify the full protocol. The decisive questions are whether the cancer and biomarker match, whether the study is genuinely open at a reachable site, what the intervention and risks are, and whether AI contributed to the drug itself rather than only to an auxiliary research task. A treating oncologist and the trial team—not a search result—must determine suitability and access.
Frequently Asked Questions
How can I check whether a trial’s AI claim has changed since I first found it?
Save the study identifier, the date you reviewed the record, and the wording that described AI. Recheck the current registry entry and ask the site to confirm any changed sponsor, intervention, or development details before making medical or travel plans.
Do I need a genetic test before contacting an AI-drug trial?
Not always. Contact the site with the reports you already have; the protocol team can tell you whether a particular mutation or assay is required and whether confirmatory testing is performed during screening.
What if the nearest site says it is not enrolling but the registry says recruiting?
Ask whether recruitment is open only at another listed location or whether the registry update is pending. Request the coordinator’s current expected opening date instead of relying on the general study status.
Can participation continue if the AI company changes or leaves the program?
That depends on the sponsor’s obligations and the protocol. Ask who supplies the intervention, who will provide follow-up, and what the consent document says about study closure or transfer before enrolling.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
